Patents by Inventor Shinichiro Aonuma

Shinichiro Aonuma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FIBER MATERIAL FOR REINFORCEMENT, PRODUCTION METHOD THEREOF, AND FIBER-REINFORCED CERAMIC COMPOSITE MATERIAL
    Publication number: 20160376201
    Abstract: The present invention relates to a fiber material for reinforcement containing a fiber aggregate containing plural fibers of a ceramic, a metal or a mixture thereof, and a porous structural body, in which the porous structural body fills a space among the plural fibers of the fiber aggregate, and covers at least a part of a surface of the fiber aggregate, and in which the porous structural body is in a state of being impregnated with a carbon material.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 29, 2016
    Inventor: Shinichiro AONUMA
  • Aluminum nitride sintered body, method of producing thereof, electrostatic chuck, susceptor, dummy wafer, clamp ring and particle catcher using the same
    Patent number: 6225249
    Abstract: The aluminum nitride sintered body of the invention has a thermal conductivity equivalent to that of a high purity aluminum nitride sintered body and a volume resistivity of 1014 &OHgr;·cm or less, and is composed of aluminum nitride phase and yttrium aluminum oxide phase formed at grain boundaries of aluminum nitride phase, where the yttrium aluminum oxide phase is 0.5 to 10 wt % in extremes for aluminum nitride phase, and contains at least one kind of lanthanide element 0.1 to 20 atom % in extremes for yttrium element.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: May 1, 2001
    Assignee: Toshiba Ceramics Co., Ltd.
    Inventors: Mitsuhiro Fujita, Shinichiro Aonuma, Kouji Sano, Shigeko Muramatsu
  • Pharmaceutical composition for treatment of osteoporosis
    Patent number: 5116828
    Abstract: A pharmaceutical composition for the treatment of osteoporosis comprises an estrogen and a thyroid hormone as effective ingredients. By using the estrogen in combination with the thyroid hormone, a more excellent activity of increasing bone amount can be obtained than in the case of administering the estrogen alone.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: May 26, 1992
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Tomoshi Miura, Shinichiro Aonuma, Hiroyuki Ohara
  • Aspirin-isopropylantipyrine
    Patent number: 4310521
    Abstract: Aspirin-isopropylantipyrine (N-3'a-propylphenazonyl-2-acetoxybenzamide) of the following formula ##STR1## and its pharmaceutical use. This compound can be prepared by reacting 1-phenyl-2-methyl-3-aminomethyl-4-isopropylpyrazolone of the formula ##STR2## with a member selected from the group consisting of acetylsalicylic acid and a reactive acid derivative thereof, and is useful as an analgetic, antipyretic and anti-inflammatory agent.
    Type: Grant
    Filed: November 7, 1980
    Date of Patent: January 12, 1982
    Assignee: Toho Pharmaceutical Co., Ltd.
    Inventor: Shinichiro Aonuma